Loading
BS
Brainscan S.A. Stock: price and insider trades · Poland
1 insider bought €129 of shares over the last 90 days, the latest by Adam Rusin, filed 24 Aug 2026.
Brainscan S.A.: what insiders have been doing
This page follows insider dealings at Brainscan S.A. as filed with KNF, a company from the Health Care sector. In the past year (22 October 2025 to 22 October 2026), 7 filings came from 4 insiders.
The flow runs one way only: 2 insiders bought (3 purchases totalling €171k) and nobody sold on the market. The amount is not disclosed for 1 filing. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. At €171k, the purchase published on 12 January 2026 by Wojciech Miśnik is the largest of the period.
The last insider purchase was made public on 24 August 2026, 61 days ago. Publication is fast: at least half of the trades appear on KNF on the same day. The regulation allows three business days to notify a trade (MAR article 19).
For context, the typical company on the same exchange (median of 553 companies) published 3 filings over the same period, against 7 filings here. Over the whole record (from 2025), the tally stands at 3 purchases and no sales.
Source: insider filings from KNF. Past trades are no guide to future returns.
Insider Decl.
7
Thresholds
n/a
Buy Volume
€171,057
3 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleAdam Rusin2 buys
Wojciech Miśnik1 buy
Since the insiders bought
- -19.2%Entry PLN 13.00 · Close at T+30 PLN 10.50
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
PLN 36.00
Income statement
RevenuePLN 193.5k
Gross profitPLN 176.2k91% margin
EBITDA-PLN 3M-1545% margin
Net income-PLN 3.1M-1580.7% margin
Balance sheet & cash
Market capPLN 17.7M
Total debtPLN 11.1k
Free Cash Flow-PLN 3.5M
Last declaration on 24 August 2026
Declarations7 total
5,589 shares@ PLN 0.100.0032% mcap100.0% of flowShareWSEKNF:node/735248
Canonical exit: 16 Nov 2026 (T+90)
●
Executives
0KNF
▲
Executives
0KNF
●
Executives
0KNF
60,000 shares@ PLN 12.00100.0% of flowShareWSEKNF:node/712874
Canonical exit: 7 Apr 2026 (T+90)
●
Executives
0KNF
●
Executives
0KNF
7 of 7 declarations
About Brainscan S.A.
Brainscan S.A. is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XWAR market.
